|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/517 | |||
| A61K 31/4184 | |||
| A61P 35/00 |
| (11) | Number of the document | 2925366 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13802815.4 |
| Date of filing the European patent application | 2013-11-26 | |
| (97) | Date of publication of the European application | 2015-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/071852 |
| Date | 2013-11-26 |
| (87) | Number | WO 2014/085381 |
| Date | 2014-06-05 |
| (30) | Number | Date | Country code |
| 201261731174 P | 2012-11-29 | US | |
| 201261731555 P | 2012-11-30 | US | |
| 201361755520 P | 2013-01-23 | US |
| (72) |
PORTER, Dale, US
EMERY, Caroline, US
TAN, Lujian, US
YERRAMILLI-RAO, Padmaja, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMBINATIONS |
| PHARMACEUTICAL COMBINATIONS |